The online version of this article (doi:10.1007/s00125-017-4402-4) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
We aimed to investigate whether diabetes cases detected through screening have better health outcomes than clinically detected cases in a population-based cohort of adults who were eligible to be screened for diabetes at 10 year intervals.
The Västerbotten Intervention Programme is a community- and individual-based public health programme in Västerbotten County, Sweden. Residents are invited to clinical examinations that include screening for diabetes by OGTTs at age 30, 40, 50 and 60 years (individuals eligible for screening, n = 142,037). Between 1992 and 2013, we identified 1024 screen-detected cases and 8642 clinically detected cases of diabetes using registry data. Clinically detected individuals were either prior screening participants (n = 4506) or people who did not participate in screening (non-participants, n = 4136). Study individuals with diabetes were followed from date of detection until end of follow-up, emigration, death or incident cardiovascular disease (CVD), renal disease or retinopathy event, and compared using Cox proportional hazard regression adjusted for calendar time, age at detection, year of detection, sex and socioeconomic status.
The average age at diabetes diagnosis was 4.6 years lower for screen-detected individuals compared with clinically detected individuals. Overall, those who were clinically detected had worse health outcomes than those who were screen-detected (HR for all-cause mortality 2.07 [95% CI 1.63, 2.62]). Compared with screen-detected study individuals, all-cause mortality was higher for clinically detected individuals who were screening non-participants (HR 2.31 [95% CI 1.82, 2.94]) than for those clinically detected who were prior screening participants (HR 1.70 [95% CI 1.32, 2.18]). Estimates followed a similar pattern for CVD, renal disease and retinopathy.
Individuals with screen-detected diabetes were diagnosed earlier and appeared to fare better than those who were clinically detected with regard to all-cause mortality, CVD, renal disease and retinopathy. How much of these associations can be explained by earlier treatment because of screening rather than healthy user bias, lead time bias and length time bias warrants further investigation.
ESM Tables (PDF 115 kb)125_2017_4402_MOESM1_ESM.pdf
International Diabetes Federation (2015) IDF diabetes atlas, 7th edn. Available from www.diabetesatlas.org/. Accessed 31 July 2017
Simmons RK, Griffin SJ, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbæk A (2017) Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults. Diabetologia DOI 10.1007/s00125-017-4323-2
Simmons RK, Griffin SJ, Lauritzen T, Sandbæk A (2017) Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia DOI 10.1007/s00125-017-4299-y
Norberg M, Wall S, Boman K, Weinehall L (2010) The Västerbotten Intervention Programme: background, design and implications. Glob Health Action 3:4643 CrossRef
Blomstedt Y, Norberg M, Stenlund H et al (2015) Impact of a combined community and primary care prevention strategy on all-cause and cardiovascular mortality: a cohort analysis based on 1 million person-years of follow-up in Västerbotten County, Sweden, during 1990-2006. BMJ Open 5:e009651 CrossRefPubMedPubMedCentral
Norberg M, Blomstedt Y, Lonnberg G et al (2012) Community participation and sustainability – evidence over 25 years in the Västerbotten Intervention Programme. Glob Health Action 5:1–9 PubMed
World Health Organization and International Diabetes Federation (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization, Geneva
Swedish National Diabetes Register (NDR). Annual reports 2007–2013. Available from www.ndr.nu/#/arsrapport [in Swedish]. Accessed 31 July 2017
Swedish National Board of Health and Welfare. The National Patient Register. Available from www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish. Accessed 31 July 2017
Swedish National Board of Health and Welfare. The Cause of Death Register. Available from www.socialstyrelsen.se/register/dodsorsaksregistret [in Swedish]. Accessed 31 July 2017
Herman WH, Ye W, Griffin SJ et al (2015) Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care 38:1449–1455 CrossRefPubMedPubMedCentral
Zelen M, Feinleib M (1969) On theory of screening for chronic diseases. Biometrika 56:601–614 CrossRef
World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization
- Screening for type 2 diabetes: do screen-detected cases fare better?
Adina L. Feldman
Simon J. Griffin
- Springer Berlin Heidelberg
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II